Lecture 32 - NK Cells 2 Flashcards
Describe the observation of improved BM transplant outcome in leukaemia
KIR-Ligand Mismatch
(Donor NK cell KIRs and host HLA mis-match)
Certain populations of donor NK cells will kill:
• Residual host DCs
→ Less Graft vs. Host disease
• Residual host T cells
→ Less rejection
• Host AML cells
→ Less relapse, clearance of tumour
This is because the NK cells do not get the appropriate inhibition signals from the host leukaemic cells, and thus are able to selectively kill them
Describe the mechanism of NK cell killing of AML cells after BM transplant
Leukaemic cells:
• Appear to lack inhibitory ligand (due to KIR mismatch)
• Have the activation ligand
NK cells become activated against leukaemic cells
Killing of cells through toxic granule release
Describe the multiple cell types that NK cells from the donor can affect
- Residual host DCs
- Residual host T cells
• Removal of patient derived T cells that would recognise the incoming graft as foreign - Host AML cells
Describe Graft versus Host Disease (GvHD)
How does mis-match attenuate GvHD?
Incoming T cells in graft start to recognise the patient as foreign
Positive selection of T cells in the thymus occurs on cortical epithelial cells
Cortical epithelial cells are patient derived (since they do not come from BM)
Negative selection of T cells in thymus occurs on DCs
DCs are BM derived and thus will be donor defied after a BM transplant
What the host perceives as foreign is dictated by the donor derived DCs
If there are residual DCs in the periphery (i.e. they haven’t all been depleted) the developing T cells won’t be tolerant of them
These DCs stimulate immune responses against the patient’s original HLA (now perceived as allogeneic)
We now get T cells that are auto-reactive against tissues all over the body
In mismatch:
• The incoming NK cells kill residual patient DCs
• These DCs can no longer prime T cell responses against host tissue
• Hence no GvHD
What are the inhibitory ligands on host cells?
Various MHC class I molecules: • HLA-A3/11 • HLA-Bw4 • HLA-C1 • HLA-C2
What are the inhibitory receptors on NK cells?
- KIR (e.g. CD158a-f)
- Ly49
- CD94/NKG2A
What are the activating receptors on NK cells?
What are the ligands for activation?
- CD2
- 2B4
- Ligands: widespread expression on host cells
(Natural cytotoxicity receptors) • NKp30 • NKp44 • NKp46 Ligands: • Unclear except: • NKp30 - B7-H6
- Activating forms of CD158/Ly49
- Ligands: unknown
- NKG2D receptor
- Ligands:
- MIC-A
- MIC-B
- ULBP(1-4)
• CD16
Compare function and structural features of CD158(L) and CD158(S)
CD158(L): inhibition receptors
• Have ITIMs
• Long cytoplasmic tail
• When stimulated, bring about inhibition of NK cells
CD158(S): activation receptors • Lack ITIMs • Short cytoplasmic tail • Associate with ITAM adaptor molecules • When stimulated, bring about activation of NK cells
Both found on NK cells
Describe NKG2D
• Where it is expressed
• Function
• Ligands (in general)
Activating receptor expressed on all NK cells and certain T cell subsets
Function:
• Very potent activation of NK cells
( • Co-stimulation of T cells)
Ligands:
•MIC-A
• MIC-B
• ULBP (1-4)
Describe the general structural features of the ligands for NKG2D
Give some examples in mice and in humans
Ligands:
• Multiple ligands
• Indicating that this receptor is promiscuous
Structural features: • MHC class I-like (have alpha helix binding cleft over β-sheet platform structure as seen on the top of MHC I molecule)
- Do not bind peptides
- Because alpha helices closer together
• Do not associate with β2-microglobulin
Examples:
– In humans –
- MIC-A/B
• MHC like proteins - ULBPs
• Family of proteins
– In mice –
- RAE
- H60
Describe how NKG2D binds to its ligands
Remember: the ligands are similar in structure to MHC I:
Alpha helices form cleft with a beta sheet platform
NKG2D binds over the two alpha helices
Sits slightly diagonally
Describe the features of expression of NKG2D ligands
Where / when are they / aren’t these ligands expressed?
NKG2D is a very potent activation receptor on NK cells
We don’t want the receptor to be activated inappropriately
This, ligand expression is tightly regulated:
Features:
1. Non-constitutive
• Low or absent in most adult tissues
2. Inducible • Heat shock Infection: • CMV • M. tuberculosis • Pathogenic E. coli • Tumours
What does expression of NKG2D ligands on cells indicate?
Expression of these ligands indicates metabolic state of stress
Describe the pathway that leads to the expression NKG2D ligands
- Viral infection
- Cell stress; DNA damage
• Cleaved dsDNA
• Stalled replication forks
→ DNA damage repair pathway activated
- Activation of protein kinases ATM or ATR
- ATM or ATR induce NKG2D ligand expression
Describe how the ‘Missing self’ hypothesis of NK cell activation has been challenged
Missing self hypothesis:
• Absence of MHC class I on a cell will lead to activation of NK cells
• NK cells kill that target cell
Now:
• NKG2D ligand expression can override the presence of MHC class I (i.e. override the inhibitory signal)
• NK cell recognition of these ligands with NKG2D receptor
• Leading to NK cell killing of that cell